Top section
Top section
◆ Have capital markets comprehended the heatwave? ◆ Which SSA issuers need to get it done this autumn ◆ Halcyon days for MTN, M&A and ECM bankers
Investors pay little heed to alarming worsening of climate
New $75m partnership to develop treatment for lymphoma was “catalyst for investors”
More articles
More articles
More articles
-
UniCredit will seek to ensure it hits its 2019 financial targets before going ahead with a bid for Germany’s Commerzbank, if the latter’s talks with Deutsche Bank collapse. -
Equity investors should double down on new listings in open trading to support their purchases. But according to many syndicate bankers, lots choose to sit on the sidelines instead, sometimes watching their investments plummet.
-
SGL Carbon issued a €250m senior secured five year on Wednesday, allowing the carbon and graphite materials firm to repay a convertible maturing next year. Despite the issuer’s chequered past, the deal saw huge demand — but the company’s decision to lock in funding now suggests tough times ahead.
-
European IPO bankers are positive about what they regard as a strong crop set to be priced before Easter, but investors are wary of committing too much.
-
Russian equity capital markets are red hot again, after almost two years in the cold, with supply being driven by some of Russia’s most powerful oligarchs. As investors warm to Russian equities, more of these billionaires are set to monetise some of their holdings, writes Sam Kerr.
-
Shares in Medacta Group, the Swiss maker of orthopaedic devices controlled by the Siccardi family, rose in the aftermarket on Thursday morning after a popular Sfr547m IPO that has been described as “textbook” by a banker at one of the global coordinators.
Sub-sections
shared comment list
